Our patented technology - Zwitterionic-bias Surface Coating Technology - is the NEW generation of bioinert and bioactive smart material, beyond HEMA, PEG and zwitterionic polymer systems. On the surface of the ZISC membrane, we create a zwitterionic-bias neutral portion with a balance amount between positively and negatively charged moieties, which provide excellent inhibition in plasma protein adsorption, blood platelet adhesion and activation, and thrombus formation. Charge-bias from the neutral portion with a controlled deviation between opposite charged moieties provide bio-specific binding...

PuriBlood Leukocyte Reductionfor Red Blood Cells High Speed Filtration An average of 30% in filtration timesaving High WBCs removal >99.99% High RBCs recovery >90% Minimal volume loss <30ml Filter housing reduction filter

I Performance summary | Volume The blood was stored at 4°C (39.2°F) and the filtration was performe at room temperature. Data | Post-filtration WBC count was determined by Nageotte method.

Pre-Storage (Blood bank use) 'Hi 1 spike / Blood clot filter / Air-vent

PuriBlood Medical was founded by Dr. Yung Chang in 2016. PuriBlood developed a unique technology for blood cell separation that is supported by a world-class research center -R&D center for membrane technology (RDCMT), which has published 1,300+ scientific papers with 25,000+ academic citations at Chung Yuan Christian University in Taiwan. PuriBlood, in conjunction with RDCMT, holds over 36+ patents supporting our core membrane technology. PuriBlood is committed to improving the blood filtration process with innovative technology of ‘Zwitterionic-bias Surface Coating Technology (ZISC technology)’...

PuriBlood www.puriblood.com The expert of cell separation PURIBLOOD MEDICAL CO., LTD &.2F, No.11, Gongye E. 9th Rd., Baoshan Township, Hsinchu County 300096, Taiwan (R.O.C.) H [email protected] +886-3-668-71 99 (3+886-3-668-7299